arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2507.06966cs.CVphysics.med-ph

用于多域深度学习配准的分割正则化训练及其在MR引导前列腺癌放疗中的应用

Segmentation Regularized Training for Multi-Domain Deep Learning Registration applied to MR-Guided Prostate Cancer Radiotherapy

Memorial Sloan Kettering Cancer Center(纪念斯隆-凯特琳癌症中心);University Medical Center Utrecht(乌得勒支大学医学中心)

Sudharsan Madhavan, Chengcheng Gui, Lando Bosma, Josiah Simeth, Jue Jiang, Nicolas Cote, Nima Hassan Rezaeian, Himanshu Nagar, Victoria Brennan, Neelam Tyagi, Harini Veeraraghavan

AI总结:

本文提出分割正则化训练的ProRSeg方法,用于MR引导前列腺癌放疗中的多域MR-MR配准,在跨域测试中表现良好,并初步验证了剂量累积评估治疗依从性的可行性。

摘要:

背景:在MR引导的自适应放疗(MRgART)中,精确的可变形图像配准(DIR)对于轮廓传播和剂量累积是必需的。本研究训练并评估了一种用于域不变MR-MR配准的深度学习DIR方法。方法:采用加权分割一致性损失,使用262对来自前列腺癌患者的3T MR模拟扫描图像训练了一种渐进细化配准与分割(ProRSeg)方法。ProRSeg在相同域(58对)、跨域(72对1.5T MR Linac图像)和混合域(42对MRSim-MRL图像)数据集上进行了测试,评估了临床靶体积(CTV)、膀胱和直肠的轮廓传播准确性。对42名接受5分次MRgART的患者进行了剂量累积。结果:ProRSeg在膀胱上表现出跨域的泛化能力,各域的Dice相似系数相似(0.88、0.87、0.86)。对于直肠和CTV,性能依赖于域,跨域MRL数据集上的准确性(DSC 0.89)高于相同域数据。该模型强大的跨域性能促使我们研究其用于剂量累积的可行性。剂量累积显示,83.3%的患者满足CTV覆盖(D95 >= 40.0 Gy)和膀胱保护(D50 <= 20.0 Gy)约束。所有患者均达到最小平均靶剂量(>40.4 Gy),但仅9.5%的患者保持在上限(<42.0 Gy)以下。结论:ProRSeg在前列腺癌患者中表现出合理的多域MR-MR配准性能,并初步证明了评估治疗依从性临床约束的可行性。

英文摘要:

Background: Accurate deformable image registration (DIR) is required for contour propagation and dose accumulation in MR-guided adaptive radiotherapy (MRgART). This study trained and evaluated a deep learning DIR method for domain invariant MR-MR registration. Methods: A progressively refined registration and segmentation (ProRSeg) method was trained with 262 pairs of 3T MR simulation scans from prostate cancer patients using weighted segmentation consistency loss. ProRSeg was tested on same- (58 pairs), cross- (72 1.5T MR Linac pairs), and mixed-domain (42 MRSim-MRL pairs) datasets for contour propagation accuracy of clinical target volume (CTV), bladder, and rectum. Dose accumulation was performed for 42 patients undergoing 5-fraction MRgART. Results: ProRSeg demonstrated generalization for bladder with similar Dice Similarity Coefficients across domains (0.88, 0.87, 0.86). For rectum and CTV, performance was domain-dependent with higher accuracy on cross-domain MRL dataset (DSCs 0.89) versus same-domain data. The model's strong cross-domain performance prompted us to study the feasibility of using it for dose accumulation. Dose accumulation showed 83.3% of patients met CTV coverage (D95 >= 40.0 Gy) and bladder sparing (D50 <= 20.0 Gy) constraints. All patients achieved minimum mean target dose (>40.4 Gy), but only 9.5% remained under upper limit (<42.0 Gy). Conclusions: ProRSeg showed reasonable multi-domain MR-MR registration performance for prostate cancer patients with preliminary feasibility for evaluating treatment compliance to clinical constraints.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑